The content on this site is intended for healthcare professionals only
Dr Josep Ribera speaks to ecancer in online video interview about the management of acute lymphoblastic leukaemia patients (ALL) during the coronavirus pandemic.
He speaks about a recent survey he carried out during the peak of the pandemic, which assessed the impact of COVID-19 on patients with ALL in Spain.
Dr Ribera explains the results of the survey, and states that the incidence of COVID-19 and ALL subtype were not linked, but notes that elderly patients were more affected.
He also outlines the main changes to treatment practices during the pandemic - in particular stem cell transplantations.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma In Rwanda: The need for further research
OncoAlert Round Up for August 25th - 31st, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The advantages of IORT for early breast cancer treatment
